71
Participants
Start Date
September 1, 2018
Primary Completion Date
December 3, 2024
Study Completion Date
December 3, 2024
Pregnenolone
In a sequential parallel comparison design, in a double blind placebo controlled study, the efficacy of pregnenlone treatment relative to placebo in improving depression and anxiety symptoms, cognition, sleep, quality of life and vasomotor symptoms in preimenopausal and menopausal women with MDD.
Placebo
In a sequential parallel comparison design, in a double blind placebo controlled study, the efficacy of pregnenlone treatment relative to placebo in improving depression and anxiety symptoms, cognition, sleep, quality of life and vasomotor symptoms in preimenopausal and menopausal women with MDD.
UT Southwestern Medical Center, Dallas
Massachusetts General Hospital
OTHER
University of Texas Southwestern Medical Center
OTHER